Social Media and Clinical Trials: Patient-Physician Interactions, Patient-Patient Interactions
View: 323
Website http://www.onlinecompliancepanel.com/webinar/SocialMediaAndClinicalTrials-501107/OCT-2015-ES |
Edit Freely
Category form 1099 due diligence, irs form 1099 penalties, accurate w-9 leads to, accurate form 1099, importance of form w-9, form 1099 accuracy, latest 1099 rules,
Deadline: October 27, 2015 | Date: October 28, 2015
Venue/Country: online Webinar, U.S.A
Updated: 2015-10-08 15:52:51 (GMT+9)
Call For Papers - CFP
Social Media and Clinical Trials: Patient-Physician Interactions, Patient-Patient InteractionsInstructor: Mukesh KumarProduct ID: 501107Objectives of the PresentationBest practices for using social media for patient-investigator interactionsIssues related to patient-patient interactions such as "Patientslikeme"Common ways companies are currently using social media in clinical trialsFDA rules for using social media in clinical trialsCrowd-sourcing, Wiki-creating, data-mining, and other social media practices for clinical trialsRecent trends in FDA enforcement actions involving social media.Why Should you AttendSocial media could be a great resource to clinical trials by highlighting specific issues, addressing concerns, educating patients and doctors alike, and engaging multiple other groups such as patient support groups, families, public policy makers, politicians, and general public. Social media can be a valuable tool to create awareness about a given trial, disease, patients, and developers. Social media is increasingly used to provide all information about the products being tested, the scientific background, and in general, educating all stakeholders. It makes it easy, accessible, timely and broadly available. While a lot of discussion has been conducted in using social media as a recruitment tool, the impact of social media goes much beyond recruitment of patients but goes into ongoing discussion between patients and investigators, investigators and sponsors, patients with other patients, and sponsor and patients.This webinar will discuss numerous ways in which social media led patient-patient, patient-investigators, investigator-sponsor, and sponsor-patient interactions and data-mining can be conducted for a better, efficient and productive clinical trial. There are also concerns about maintaining trial integrity, logistical affability, and financial feasibility of using social media in clinical trials. FDA rules and industry practices will be discussed in light of the technological challenges with using social media in clinical trials.Who can BenefitClinical Project ManagersClinical Research AssociatesClinical CoordinatorsPrinciple InvestigatorsCompliance ManagersRegulatory Vice Presidents, Directors and ManagersAttorneys - In-house or Outside CounselSenior executives of Pharmaceutical and Device FirmsFor Registration -http://www.onlinecompliancepanel.com/webinar/SocialMediaAndClinicalTrials-501107/OCT-2015-ESNote : Use coupon code 1371 and get 10% off on Registration
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.